Profile

PhD, Moscow State University
MS, Moscow State University




Complex Role of Hsf1 in Breast Cancer
03/01/2014 - 02/28/2019 (PI)
Beth Israel Deaconess Medical Center, Inc NIH NCI
5R01CA176326-03

Agreement with SpalRx
12/01/2016 - 12/31/2017 (PI)
SpalRx Ltd


The Role of p62 in Cancer
07/01/2015 - 12/31/2015 (PI)
SL Oncology


Heat shock proteins in signaling and cancer
09/29/2009 - 08/31/2015 (PI)
NIH/National Cancer Institute
5R01CA081244-15

Testing of sponsor's materials in cell cultures and animal models
02/15/2014 - 06/30/2015 (PI)
SL Oncology


Age Dependence of Breast Cancer
07/01/2013 - 06/30/2015 (PI)
NIH/National Cancer Institute
5R21CA178563-02

Anti-cancer Immunization
02/15/2013 - 12/31/2014 (PI)
SL Oncology


HEAT SHOCK PROTEINS IN CANCER AND SIGNALING
09/29/2009 - 08/31/2014 (PI)
NIH/National Cancer Institute
5R01CA081244-13

THE MIT CENTER FOR SINGLE-CCELL DYNAMICS IN CANCER (SCDC)
08/01/2010 - 07/31/2014 (PI)
Massachusetts Institute of Technology NIH NCI
5U54CA143874-05

Cell Mechanisms of Abnormal Protein Aggregation
07/01/2004 - 02/28/2013 (PI)
NIH/National Institute of General Medical Sciences
5R01GM086890-08

Showing 10 of 13 results. Show All Results



Yr Title Project-Sub Proj Pubs
2018 Complex Role of HSF1 in Breast Cancer 5R01CA176326-05 7
2017 Complex Role of HSF1 in Breast Cancer 5R01CA176326-04 7
2015 Complex Role of HSF1 in Breast Cancer 5R01CA176326-02 7
2014 Complex Role of HSF1 in Breast Cancer 1R01CA176326-01A1 7
2014 Age Dependence of Breast Cancer 5R21CA178563-02 1
2013 Age Dependence of Breast Cancer 1R21CA178563-01 1
2013 Heat shock proteins in signaling and cancer 5R01CA081244-15 11
2012 Cellular Mechanisms of Aggregation of Abnormal Proteins 5R01GM086890-08 6
2012 Heat shock proteins in signaling and cancer 5R01CA081244-14 11
2011 CHARACTERIZATION OF HUNTINGTON AND PARKINSON AGGREGATES BY MASS SPECTROMETRY 5P41RR010888-15-5120 236
Showing 10 of 41 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Yaglom JA, Wang Y, Li A, Li Z, Monti S, Alexandrov I, Lu X, Sherman MY. Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations. Sci Rep. 2018 Feb 14; 8(1):3010.View Related Profiles. PMID: 29445088.
     
  2. Gabai VL, Meng L, Kim G, Mills TA, Benjamin IJ, Sherman MY. Correction for Gabai et al., "Heat Shock Transcription Factor Hsf1 Is Involved in Tumor Progression via Regulation of Hypoxia-Inducible Factor 1 and RNA-Binding Protein HuR". Mol Cell Biol. 2017 Oct 15; 37(20).View Related Profiles. PMID: 28951485.
     
  3. Halenova T, Savchuk O, Ostapchenko L, Chursov A, Fridlyand N, Komissarov AB, Venanzi F, Kolesnikov SI, Sufianov AA, Sherman MY, Gabai VL, Shneider AM. P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions. Oncotarget. 2017 Aug 22; 8(34):56030-56040.View Related Profiles. PMID: 28915571.
     
  4. McFarland CD, Yaglom JA, Wojtkowiak JW, Scott JG, Morse DL, Sherman MY, Mirny LA. The Damaging Effect of Passenger Mutations on Cancer Progression. Cancer Res. 2017 Sep 15; 77(18):4763-4772.View Related Profiles. PMID: 28536279.
     
  5. Athanasiou D, Aguila M, Opefi CA, South K, Bellingham J, Bevilacqua D, Munro PM, Kanuga N, Mackenzie FE, Dubis AM, Georgiadis A, Graca AB, Pearson RA, Ali RR, Sakami S, Palczewski K, Sherman MY, Reeves PJ, Cheetham ME. Rescue of mutant rhodopsin traffic by metformin-induced AMPK activation accelerates photoreceptor degeneration. Hum Mol Genet. 2017 Jan 15; 26(2):305-319. PMID: 28065882; DOI: 10.1093/hmg/ddw387;.
     
  6. Gabai VL, Yaglom JA, Wang Y, Meng L, Shao H, Kim G, Colvin T, Gestwicki J, Sherman MY. Anticancer Effects of Targeting Hsp70 in Tumor Stromal Cells. Cancer Res. 2016 Oct 15; 76(20):5926-5932.View Related Profiles. PMID: 27503927.
     
  7. Lee do H, Sherman MY, Goldberg AL. The requirements of yeast Hsp70 of SSA family for the ubiquitin-dependent degradation of short-lived and abnormal proteins. Biochem Biophys Res Commun. 2016 Jun 17; 475(1):100-6. PMID: 27178214; DOI: 10.1016/j.bbrc.2016.05.046;.
     
  8. Zaarur N, Xu X, Lestienne P, Meriin AB, McComb M, Costello CE, Newnam GP, Ganti R, Romanova NV, Shanmugasundaram M, Silva ST, Bandeiras TM, Matias PM, Lobachev KS, Lednev IK, Chernoff YO, Sherman MY. RuvbL1 and RuvbL2 enhance aggresome formation and disaggregate amyloid fibrils. EMBO J. 2015 Sep 14; 34(18):2363-82.View Related Profiles. PMID: 26303906; PMCID: PMC4570522; DOI: 10.15252/embj.201591245;.
     
  9. Sabbieti MG, Agas D, Capitani M, Marchetti L, Concetti A, Vullo C, Catone G, Gabai V, Shifrin V, Sherman MY, Shneider A, Venanzi FM. Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent. Oncotarget. 2015 Feb 28; 6(6):3590-9.View Related Profiles. PMID: 25668818; PMCID: PMC4414139.
     
  10. Gong J, Weng D, Eguchi T, Murshid A, Sherman MY, Song B, Calderwood SK. Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis. Oncogene. 2015 Oct; 34(43):5460-71.View Related Profiles. PMID: 25659585; DOI: 10.1038/onc.2015.1;.
     
Showing 10 of 93 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.


Contact for Mentoring: